8,153
edits
Changes
no edit summary
{{Skeleton}}
* '''Epilepsy'''. The use of the [[Ketogenic Diets for Epilepsy]] is well established.
* '''Cancer'''. The Ketogenic Diet may help with the treatment of cancer. The current evidence suggests to me that the Ketogenic Diet is unlikely to be an alternative to conventional treatments, but rather a supplement. The evidence so far is limited, but animal studies as well as the case of two children with inoperable brain tumors that regressed under the ketogenic diet are promising (Nebeling, seyfried, zuccoli).
** Most cancers, including brain tumors depend on glucose and they cannot metabolize ketones.
** Cancers promote the growth of new blood vessels, something the ketogenic diet inhibits, as Ketones are [http://en.wikipedia.org/wiki/Angiogenesis_inhibitor anti-angiogenic].
** Cancer cells often don't undergo natural cell death, something the ketogenic diet also enhances.
* '''Hypoxia. '''There are a number of medical conditions that reduce the supply of oxygen (hypoxia), and the Ketogenic Diet may reduce the damage that occurs as a result. ''' ''' ** '''Head trauma'''. Head trauma often results in a rapid increase in cerebral glucose metabolism, followed but a prolonged decrease. Administering glucose to patients tends to result in hyperglycemia (high blood sugar) that worsens the outcome. In animal studies, fasting or a ketogenic diet improves tissue preservation, but further research is needed.** '''Stroke'''. Because a stroke involves the reduction of blood flow to areas of the brain, the Ketogenic diet may help reduce the resulting damage. ([http://www.ncbi.nlm.nih.gov/pubmed/23050642 http://www.ncbi.nlm.nih.gov/pubmed/23050642]) ** '''Altitude Sickness'''. It is possible that the ketogenic diet may help with altitude sickness (Acute Mountain Sickness), but more research is needed. (Personally, I've found I can tolerate my lower oxygen levels during [[Altitude Training]] while on the ketogenic diet.)* '''Heart disease'''. The effect of the ketogenic diet on heart disease risk is unclear. There are some concerns that the ketogenic diet raises blood lipids, and this in turn may increase the risk for heart disease. However, some studies have shown that the ketogenic diet improves markers associated with the risk of heart disease ([http://jn.nutrition.org/content/132/7/1879.short http://jn.nutrition.org/content/132/7/1879.short]). * '''Alzheimer's disease (AD)'''. AD is a degenerative neurological condition characterized by memory loss and there is currently no treatment. There is some evidence that a ketogenic diet may not only improve the symptoms of AD<ref name="KrikorianShidler2012"/>, but may also modify the disease activity itself. The benefits of the ketogenic diet may also have benefits for other neurological conditions involving neuron death. There is evidence that raising Ketone levels through MCT supplementation without carbohydrate restriction also improve memory function in AD sufferers<ref name="RegerHenderson2004"/>. A drug called Axona was introduced in 2009 as an FDA approved "medical food" and it consists of a MCT oil (caprylic acid).* '''Parkinson's disease'''. Animal studies and anecdotal reports suggest that the ketogenic diet may reverse the symptoms of Parkinson's disease, but there are no published human studies. * '''Amyotropic Lateral Sclerosis (ALS)'''. Like Parkinson's disease, there is currently only animal and anecdotal reports of success, but human studies are under way. * '''Type 1 diabetes'''. At one time, type 1 diabetes (previously called childhood diabetes) was expected to be fatal within a year. The first approach was a starvation diet of 450 calories per day, which lead Fredrick M Allen to use a 70% fat, 8% carbohydrate diet that was the standard treatment before the discovery of insulin. * '''Autism'''. There are early reports from a Greek study in Crete indicating that the ketogenic diet may produce some improvement in some children. There are also anecdotal reports of epileptic children treated with the ketogenic diet also having improvements in their autism. * '''Inflammatory disease'''.* '''Migraine'''. While a 1930's textbook talks of the possibility of the ketogenic diet helping with migraines, a study of 8 teenagers with severe migraines at John Hopkins showed the ketogenic diet was ineffective.* '''Severe hyperactivity'''. There are initial reports that the ketogenic diet improves hyperactivity in animal reports, and some anecdotal reports of the benefit in humans. As with Autism, there are also reports of epileptic children treated with the ketogenic diet also having improvements in their hyperactivity. * '''Schizophrenia'''. There is a case report of a radical improvement in schizophrenia with the ketogenic diet. However, this may be due to a removal of the gluten from the diet rather than the overall dietary changes. * '''Depression and bipolar disorder'''. There are a number of cases that have been reported where the ketogenic diet helps normalize the [[Mood State]] of those with bipolar disorder<ref name="El-MallakhPaskitti2001"/>. One report indicated that over 2-3 years the mood stabilization exceeded that achieved with medication<ref name="Phelps-2013"/>.
{{KetoSeeAlso}}
=References=
<references>
<ref name="El-MallakhPaskitti2001">R.S. El-Mallakh, M.E. Paskitti, The ketogenic diet may have mood-stabilizing properties, Medical Hypotheses, volume 57, issue 6, 2001, pages 724–726, ISSN [http://www.worldcat.org/issn/03069877 03069877], doi [http://dx.doi.org/10.1054/mehy.2001.1446 10.1054/mehy.2001.1446]</ref>
<ref name="Phelps-2013"> JR. Phelps, SV. Siemers, RS. El-Mallakh, The ketogenic diet for type II bipolar disorder., Neurocase, volume 19, issue 5, pages 423-6, 2013, doi [http://dx.doi.org/10.1080/13554794.2012.690421 10.1080/13554794.2012.690421], PMID [http://www.ncbi.nlm.nih.gov/pubmed/23030231 23030231]</ref>
<ref name="KrikorianShidler2012">Robert Krikorian, Marcelle D. Shidler, Krista Dangelo, Sarah C. Couch, Stephen C. Benoit, Deborah J. Clegg, Dietary ketosis enhances memory in mild cognitive impairment, Neurobiology of Aging, volume 33, issue 2, 2012, pages 425.e19–425.e27, ISSN [http://www.worldcat.org/issn/01974580 01974580], doi [http://dx.doi.org/10.1016/j.neurobiolaging.2010.10.006 10.1016/j.neurobiolaging.2010.10.006]</ref>
<ref name="RegerHenderson2004">Mark A. Reger, Samuel T. Henderson, Cathy Hale, Brenna Cholerton, Laura D. Baker, G.S. Watson, Karen Hyde, Darla Chapman, Suzanne Craft, Effects of β-hydroxybutyrate on cognition in memory-impaired adults, Neurobiology of Aging, volume 25, issue 3, 2004, pages 311–314, ISSN [http://www.worldcat.org/issn/01974580 01974580], doi [http://dx.doi.org/10.1016/S0197-4580(03)00087-3 10.1016/S0197-4580(03)00087-3]</ref>
</references>